Table 2 Hazard ratios (HRs) of mortality, and corresponding 95% confidence intervals (CIs), according to selected clinical and pathological characteristics, among 841 triple-negative breast cancers (TNBCs). Sardinia, Italy 1994–2015

1.00^c

1.00^c

1.04 (0.59–1.84)

0.66 (0.31–1.42)

0.56 (0.30–1.02)

0.40 (0.21–0.76)

1.00^c

1.00^c

1.12 (0.77–1.63)

0.96 (0.58–1.58)

1.00^c

1.00^c

2.71 (1.74–4.23)

2.41 (1.40–4.15)

2.85 (1.46–5.55)

2.24 (1.00–5.06)

8.13 (4.44–14.9)

5.13 (2.21–11.9)

1.00^c

1.00^c

2.63 (1.69–4.10)

2.04 (1.22–3.40)

3.54 (2.06–6.06)

3.11 (1.70–5.68)

6.10 (3.44–10.8)

3.18 (1.51–6.71)

1.00^c

1.00^c

6.01 (2.72–13.3)

5.13 (1.69–15.6)

1.00^c

1.00^c

3.09 (1.59–6.00)

3.13 (1.56–6.27)

9.68 (5.02–18.7)

9.65 (4.66–20.0)

19.8 (7.54–51.9)

29.0 (9.65–86.9)

1.00^c

1.00^c

1.24 (0.85–1.80)

1.20 (0.76–1.91)

1.00^c

1.00^c

2.45 (1.71–3.51)

1.49 (0.93–2.38)

1.00^c

1.00^c

1.58 (1.11–2.24)

1.61 (1.03–2.51)

1.00^c

1.00^c

2.15 (1.21–3.83)

2.19 (1.03–4.66)

1.45 (0.79–2.65)

1.65 (0.71–3.84)

1.46 (0.76–2.80)

1.69 (0.70–4.09)

2.00 (1.14–3.51)

2.37 (1.08–5.21)